XML 19 R8.htm IDEA: XBRL DOCUMENT
v3.22.4

LOSS PER SHARE AND STOCKHOLDERS’ EQUITY | 9 Months Ended
--- | ---
Dec. 31, 2022
EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS' EQUITY |
LOSS PER SHARE AND STOCKHOLDERS’ EQUITY | LOSS PER SHARE AND STOCKHOLDERS’ EQUITY: Loss Per Share A reconciliation of the numerator and denominator of basic and diluted loss per share is shown below (in thousands, except per share amounts):
|  | For the three months ended |  | For the nine months ended
|  | December 31, |  | December 31,
|  | 2022 |  | 2021 |  | 2022 |  | 2021
Basic earnings (loss) per share: |  |  |  |  |  |  |  |
Net loss from continuing operations |  | $ | (30,520) |  |  | $ | (15,375) |  |  | $ | (88,174) |  |  | $ | (4,441) |
Earnings from discontinued operations, net of tax |  | 836 |  |  | — |  |  | 836 |  |  | — |
Net loss |  | $ | (29,684) |  |  | $ | (15,375) |  |  | $ | (87,338) |  |  | $ | (4,441) |
Basic weighted-average shares outstanding |  | 64,784 |  |  | 68,190 |  |  | 66,761 |  |  | 68,187 |
Continuing operations |  | $ | (0.47) |  |  | $ | (0.23) |  |  | $ | (1.32) |  |  | $ | (0.07) |
Discontinued operations |  | 0.01 |  |  | — |  |  | 0.01 |  |  | — |
Basic loss per share |  | $ | (0.46) |  |  | $ | (0.23) |  |  | $ | (1.31) |  |  | $ | (0.07) |
Diluted earnings (loss) per share: |  |  |  |  |  |  |  |
Basic weighted-average shares outstanding |  | 64,784 |  |  | 68,190 |  |  | 66,761 |  |  | 68,187 |
Dilutive effect of common stock options and restricted stock as computed under the treasury stock method (1) |  | — |  |  | — |  |  | — |  |  | — |
Diluted weighted-average shares outstanding |  | 64,784 |  |  | 68,190 |  |  | 66,761 |  |  | 68,187 |
Continuing operations |  | $ | (0.47) |  |  | $ | (0.23) |  |  | $ | (1.32) |  |  | $ | (0.07) |
Discontinued operations |  | 0.01 |  |  | — |  |  | 0.01 |  |  | — |
Diluted loss per share |  | $ | (0.46) |  |  | $ | (0.23) |  |  | $ | (1.31) |  |  | $ | (0.07) |
Loss per share totals may not sum due to rounding. |  |  |  |
(1) The number of common stock options and restricted stock units as computed under the treasury stock method that would have otherwise been dilutive but are excluded from the table above because their effect would have been anti-dilutive due to the net loss position of the Company was 0.5 million and 1.7 million in the three months ended December 31, 2022 and 2021, respectively, and 0.6 million and 1.4 million in the nine months ended December 31, 2022 and 2021, respectively. Restricted stock units that were outstanding during the periods presented but were not included in the computation of diluted earnings (loss) per share because their effect would have been anti-dilutive (other than due to the net loss position of the Company) are shown below (shares in thousands):
|  | For the three months ended |  | For the nine months ended
|  | December 31, |  | December 31,
|  | 2022 |  | 2021 |  | 2022 |  | 2021
Number of shares underlying restricted stock units |  | 6,215 |  |  | 484 |  |  | 2,980 |  |  | 787 |
Stockholders’ Equity On December 20, 2022, the Company's Board of Directors approved an amendment to the existing common stock repurchase program, which was initially adopted in 2011. The amendment authorized an additional $100.0 million in share repurchases, increasing the total amount authorized for repurchase under the common stock repurchase program to $1.1 billion. In addition, it extended the common stock repurchase program duration through December 31, 2024. During the nine months ended December 31, 2022, the Company repurchased 6.1 million shares of its common stock for $150.0 million under the modified common stock repurchase program. Through December 31, 2022, the Company had repurchased a total of 35.6 million shares of its stock for $882.2 million under the program, leaving remaining capacity of $217.8 million. Accumulated other comprehensive income balances of $4.2 million and $5.7 million at December 31, 2022 and March 31, 2022, respectively, reflect accumulated foreign currency translation adjustments.

X
- References No definition available. + Details
Name: | ramp_EARNINGSLOSSPERSHAREANDSTOCKHOLDERSEQUITY
Namespace Prefix: | ramp_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ramp_EarningsPerShareAndStockholdersEquityDisclosureTextBlock
Namespace Prefix: | ramp_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration